U.S. markets closed
  • S&P Futures

    4,391.25
    +7.25 (+0.17%)
     
  • Dow Futures

    34,200.00
    +71.00 (+0.21%)
     
  • Nasdaq Futures

    15,186.25
    +22.75 (+0.15%)
     
  • Russell 2000 Futures

    2,219.20
    +4.30 (+0.19%)
     
  • Crude Oil

    72.03
    -0.20 (-0.28%)
     
  • Gold

    1,766.30
    -12.50 (-0.70%)
     
  • Silver

    22.66
    -0.25 (-1.08%)
     
  • EUR/USD

    1.1690
    -0.0005 (-0.05%)
     
  • 10-Yr Bond

    1.3360
    +0.0120 (+0.91%)
     
  • Vix

    20.87
    -3.49 (-14.33%)
     
  • GBP/USD

    1.3617
    -0.0003 (-0.02%)
     
  • USD/JPY

    109.8810
    +0.1030 (+0.09%)
     
  • BTC-USD

    43,400.00
    +2,722.78 (+6.69%)
     
  • CMC Crypto 200

    1,090.64
    +50.16 (+4.82%)
     
  • FTSE 100

    7,083.37
    +102.39 (+1.47%)
     
  • Nikkei 225

    29,639.40
    -200.31 (-0.67%)
     

DarioHealth to Report Financial Results for the Third Quarter 2020 on November 12

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Earnings Discussion and Business Update Scheduled for 9:00 am Eastern Time

NEW YORK, Nov. 4, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it would release its second quarter ended September 30, 2020, financial results on Thursday, November 12, 2020, and host a conference call at 9:00 am Eastern Time.

Dario Health (PRNewsfoto/DarioHealth Corp.)
Dario Health (PRNewsfoto/DarioHealth Corp.)

Erez Raphael, Chief Executive Officer, Rick Anderson, President and General Manager of North America, and Zvi Ben-David, Chief Financial Officer will host the call.

Conference Call Details

Date: Thursday, November 12, 2020
Time: 9:00 am EDT
Toll-Free: 844-369-8770
International: 862-298-0840
Conference ID: DarioHealth Third Quarter 2020 Earnings Call and Webcast
Webcast: https://www.webcaster4.com/Webcast/Page/2224/38235

Participants are asked to dial in-10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through November 26, 2020. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 38235. The webcast replay will be available through February 12, 2021.

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. By delivering evidence-based interventions driven by data, high-quality software, and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™ mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, please go to: https://www.dariohealth.com.

Logo - http://mma.prnewswire.com/media/544126/DarioHealth_Logo.jpg

DarioHealth Contact:

Claudia Levi
Content & Communications Manager
claudia@mydario.com
+1-347-767-4220

Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1-646-627-8390

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/dariohealth-to-report-financial-results-for-the-third-quarter-2020-on-november-12-301166295.html

SOURCE DarioHealth Corp.